AAAAAA

   
Results: 1-14 |
Results: 14
HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL
Authors: GALLIGIONI E CETTO G NASCIMBEN O BUONADAONA A CRIVELLARI D MOLINO A VERONESI A GRAIFF C BARNI S PUCCETTI C FERRAZZI E RECALDIN E SAVA C SARACCHINI S SACCO C
Citation: E. Galligioni et al., HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 84-84
EFFICACY OF MITOXANTRONE, 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN COMBINATION IN ELDERLY PATIENTS WITH METASTATIC BREAST-CANCER
Authors: NASCIMBEN O BIASON R DAMANZO P GATTI C ONIGA F MEDICI M PACCAGNELLA A
Citation: O. Nascimben et al., EFFICACY OF MITOXANTRONE, 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN COMBINATION IN ELDERLY PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 126-126
MITOXANTRONE (MX), 5-FLUOROURACIL (5-FU) AND HIGH-DOSE LEVO-FOLINIC ACID (HD-LFA) IN WIDELY METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER (HRPC)
Authors: MAGAROTTO R NASCIMBEN O CIRILLO M PICECE V MOLON A PASTORELLO M BIASON R RECALDIN E
Citation: R. Magarotto et al., MITOXANTRONE (MX), 5-FLUOROURACIL (5-FU) AND HIGH-DOSE LEVO-FOLINIC ACID (HD-LFA) IN WIDELY METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER (HRPC), Annals of oncology, 9, 1998, pp. 168-168
MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL
Authors: AMADORI D FRASSINETI GL DEMATTEIS A MUSTACCHI G SANTORO A CARIELLO S FERRARI M NASCIMBEN O NANNI O LOMBARDI A SCARPI E ZOLI W
Citation: D. Amadori et al., MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Breast cancer research and treatment, 49(3), 1998, pp. 209-217
SURGICAL 2ND LOOK IN OVARIAN-CANCER - A RANDOMIZED STUDY IN PATIENTS WITH LAPAROSCOPIC COMPLETE REMISSION - A NORTHEASTERN ONCOLOGY COOPERATIVE GROUP OVARIAN-CANCER COOPERATIVE GROUP-STUDY
Authors: NICOLETTO MO TUMOLO S TALAMINI R SALVAGNO L FRANCESCHI S VISONA E MARIN G ANGELINI F BRIGATO G SCARABELLI C CARBONE A CECCHETTO A PROSPERI A ROSABIAN A GIUSTO M CIMA GP MORASSUT S NASCIMBEN O VINANTE O FIORENTINO MV
Citation: Mo. Nicoletto et al., SURGICAL 2ND LOOK IN OVARIAN-CANCER - A RANDOMIZED STUDY IN PATIENTS WITH LAPAROSCOPIC COMPLETE REMISSION - A NORTHEASTERN ONCOLOGY COOPERATIVE GROUP OVARIAN-CANCER COOPERATIVE GROUP-STUDY, Journal of clinical oncology, 15(3), 1997, pp. 994-999
QUANTITATIVE CHEMILUMINESCENT IMMUNOASSAY OF P53 - PROGNOSTIC-SIGNIFICANCE IN 220 NODE-NEGATIVE BREAST-CANCER TISSUE
Authors: DITTADI R BRAZZALE A MIONE R DIFRESCO S GATTI C VINANTE O BASSAN F NASCIMBEN O GION M
Citation: R. Dittadi et al., QUANTITATIVE CHEMILUMINESCENT IMMUNOASSAY OF P53 - PROGNOSTIC-SIGNIFICANCE IN 220 NODE-NEGATIVE BREAST-CANCER TISSUE, Anticancer research, 17(6D), 1997, pp. 4691-4696
ERBB2 ASSAY IN BREAST-CANCER - POSSIBLY IMPROVED CLINICAL INFORMATIONUSING A QUANTITATIVE METHOD
Authors: DITTADI R BRAZZALE A PAPPAGALLO G SALBE C NASCIMBEN O ROSABIAN A GION M
Citation: R. Dittadi et al., ERBB2 ASSAY IN BREAST-CANCER - POSSIBLY IMPROVED CLINICAL INFORMATIONUSING A QUANTITATIVE METHOD, Anticancer research, 17(2B), 1997, pp. 1245-1247
LONIDAMINE PLUS EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: GARDIN G BARONE C NASCIMBEN O IANNIELLO G STURBA F CONTU A PRONZATO P ROSSO R
Citation: G. Gardin et al., LONIDAMINE PLUS EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 32A(1), 1996, pp. 176-177
EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER
Authors: LABIANCA R MARSONI S PANCERA G TORRI V ZANIBONI A ERLICHMAN C PATER J SHEPHERD L ZEE B SEITZ JF MILAN C PIGNON JP AITINI E APOLONE G AUZZANI A BANDUCCI S BARNI S BERETTA GD BIFFI O BUCCI F CARDI G CIFATTE D COLUCCI G COMANDONE A COMELLA G CONFALONIERI C CONFU A COSTANZO M CRESPI C DAMIANI E DEGIORGI D DONGIOVANNI V FABRIS G FABRIZIO G FACENDOLA G FANTONI PA FERRAGNI A FIORI B FLORIANELLO F FRONTINI L GALLI E GARATTINI P GHERARDI G GIOVANELLI A GUILIANI F GOSSO P JANNIELLO GP KILDANI B LEO S LIBERATI A MAFFIONE G MAIELLO E MAIORINO L MANENTE P MARTIGNONI GC MARZOLA M MASTRODONATO M MERIGGI F MOLINARI B MOLINARI GF MONFERRONI N NASCIMBEN O NATALE C NEGRETTI S PALAZZO S PANVINI D PARISI V PEDICINI T PERADOTTO F PESSA S PIATTO E PIZZI G PROSPERI A PRUSCIANO F RABBI C RAINA A RUGGIERO A SAVA C SCANZI F CARRARO PS SMERIERI F STIVALA B TAIANA A TARDIO B TESTORE F TINAZZI A TURCATO G ZONATO S AYOUB J BELANGER K BIRON G BODURTHA AJ BOOS G BURNELL M CANO P CHARPENTIER D CHOW WSW CHRITCHLEY J CRIPPS C DANG SP DAVIS ML DAVIDSON M DINGLE B DRYER D FERLAND E FIELDS A FINE S JOLIVET J KAISER L KERR I KOCHA WI KOTWALL C KRIEGER H LEPINEMARTIN M LITTLE C LOFTERS WS MAHEU M MOORE M PRESSNAIL B RAGAZ J RAUNER H REZNICK R ROSS T ROTSTEIN L RUDINSKAS L SCHACTER B SHAH A SKILLINGS J STERN H TWEEDDALE M VANDENBERG T WALDE D WATT HJ WONG KWA YOSHIDA S BALDIT C BARONI JL BAZIN JP BEDENNE L BLANCHI A BOGNEL JC BOSSET JF BOUCHE O BRANDONE JM BRICOT R BURTIN P CADOR L CHARBIT M CHARLIER A COUROUBLE Y COUZIGOU P CUILLERET J DELPERO JR DUCREUX M DUMAS F ECHINARD E ETIENNE PL FRIGUET JL GIGNOUX M GIOVANNINI M HERR JP LAFON J LETREUT P LATRIVE JP LAUVAUX C LOUVET C MACKIEWICZ R MAUREL C MESSERSCHMITT C MORAND L MOREAU J MORIN T NORDLINGER B NOTERDAEME PM OLLIER JC PICAUD R PEINKOWSKI P PLACHOT JP PORTET R DUBATY HR ROUGIER P ROZENTAL G SASTRE B VOTTELAMBERT A WATRIN B ZEITOUN P
Citation: R. Labianca et al., EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8955), 1995, pp. 939-944
CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY
Authors: VERONESI A CARTEI G CRIVELLARI D MAGRI MD DELLAVALENTINA M FOLADORE S TROVO MG NASCIMBEN O SIBAU A TALAMINI R MONFARDINI S
Citation: A. Veronesi et al., CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY, European journal of cancer, 30A(10), 1994, pp. 1474-1478
CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY
Authors: VERONESI A CARTEI G CRIVELLARI D MAGRI MD DELLAVALENTINA M FOLADORE S TROVO MG NASCIMBEN O SIBAU A TALAMINI R MONFARDINI S
Citation: A. Veronesi et al., CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY, European journal of cancer, 30A(10), 1994, pp. 1474-1478
BIOCHEMICAL PARAMETERS FOR PROGNOSTIC EVALUATION IN PATIENTS WITH BREAST-CANCER
Authors: GION M MIONE R PAPPAGALLO GL GATTI C NASCIMBEN O SAMPOGNARO E MEO S
Citation: M. Gion et al., BIOCHEMICAL PARAMETERS FOR PROGNOSTIC EVALUATION IN PATIENTS WITH BREAST-CANCER, Anticancer research, 14(2B), 1994, pp. 693-698
IMPACT OF FOLLOW-UP TESTING ON SURVIVAL AND HEALTH-RELATED QUALITY-OF-LIFE IN BREAST-CANCER PATIENTS - A MULTICENTER RANDOMIZED CONTROLLED TRIAL
Authors: GHEZZI P MAGNANINI S RINALDINI M BERARDI F DIBIAGIO G TESTORE F TAVONI N SCHITTULLI F DAMICO C PEDICINI T FUMAGALLI M GRITTI G BRAGA M MARINI G ZANIBONI A COSENTINO D EPIFANI C GINI G PERRONI D PERADOTTO F INDELLI M SANTINI A ISA L AITINI E CAVAZZINI G SMERIERI F NASCIMBEN O BUSOLIN R PAPACCIO G LOCATELLI E MONTI M GHISLANDI E GOTTARDI O MAJNO M PLUCHINOTTA A ARMAROLI L CONFALONIERI C VIOLA P GALLETTO L SUSSIO M TROLLI B BIASIO M ROLFO A VAUDANO G GIOLITO MR AMBROSINI G BUSANA L MOLTENI M RICHETTI A MARUBINI E PIFFANELLI A SALVADORI B TOGNONI G ZOLA P LIBERATI A FOSSATI R MEYEROWITZ BE TORRI V APOLONE G MOSCONI P MARSONI S LIBERATI MC ALEXANIAN A GRILLI R NICOLUCCI A MONFERRONI N
Citation: P. Ghezzi et al., IMPACT OF FOLLOW-UP TESTING ON SURVIVAL AND HEALTH-RELATED QUALITY-OF-LIFE IN BREAST-CANCER PATIENTS - A MULTICENTER RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(20), 1994, pp. 1587-1592
PS2 IN BREAST-CANCER - ALTERNATIVE OR COMPLEMENTARY TOOL TO STEROID-RECEPTOR STATUS - EVALUATION OF 446 CASES
Authors: GION M MIONE R PAPPAGALLO GL GATTI C NASCIMBEN O BARI M LEON AE VINANTE O BRUSCAGNIN G
Citation: M. Gion et al., PS2 IN BREAST-CANCER - ALTERNATIVE OR COMPLEMENTARY TOOL TO STEROID-RECEPTOR STATUS - EVALUATION OF 446 CASES, British Journal of Cancer, 68(2), 1993, pp. 374-379
Risultati: 1-14 |